www.pharmablog.nl

Weblog met nieuws over de pharmaceutische industrie

Archive for the ‘3’ Category

UnitedHealthcare is the first national health plan to partner with the California Regional Health Information Organization and agree to pay for electronic health information services statewide.

Lees meer..

  • 0 Comments
  • Filed under: 3
  • Dr. Nicole Onetto will step down as senior vice president and chief medical officer of ZymoGenetics Inc., the biotech company said Thursday in a regulatory filing. (ZGEN)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Initial results from three pivotal phase III trials show the Novartis investigational bronchodilator QAB149 (indacaterol) could deliver clinically relevant* lung function improvements, within five minutes of the first dose, lasting for 24 hours in patients with chronic obstructive pulmonary disease (COPD)[3],[4],[5].
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Novartis has signed a definitive agreement to acquire the specialty generic injectables business of EBEWE Pharma, providing Sandoz - the Group’s generic pharmaceuticals division - an opportunity to create a strong global platform for future growth while improving access for patients worldwide to many generic oncology medicines.
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Novartis has assumed exclusive worldwide rights to develop and commercialize QMF149, a fixed-combination of its investigational QAB149 (indacaterol) with Schering-Plough Corporation’s inhaled corticosteroid mometasone, in changes announced today to the companies’ collaboration to develop fixed-dose combination respiratory therapies.
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • ISO 9001:2008 Successful Certification process coincides with HP Mile’s expanding customer base and new facility.
    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Florida Sen. Michael Bennett is requesting the ouster of Insurance Commissioner Kevin McCarty in a letter sent to Gov. Charlie Crist Thursday.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • Genzyme Corp. announced Thursday that it has addressed regulatory concerns holding up its ability to ramp up production of its Pompe disease drug Lumizyme.

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • A Buffalo drug development company has signed a new joint venture to develop compounds for cancer applications. (CBLI)

    Lees meer..

  • 0 Comments
  • Filed under: 3
  • The legislative budget conference committee has earmarked $16 million in the state’s preliminary budget to help the continued expansion of the Texas A&M Health Sciences Center campus in Round Rock.

    Lees meer..

  • 0 Comments
  • Filed under: 3